10 Common Mistakes in OBG NEET PG — And How to Avoid Them
Avoid the 10 costliest obstetrics and gynecology mistakes in NEET PG 2026: confused stages of labor, mixed-up APH causes (previa vs abruption vs vasa previa), wrong MgSO4 toxicity sequence, teratogenic drugs by trimester, confused ovarian tumors, outdated cervical cancer FIGO staging, emergency contraception choices, partograph misreading, wrong PPH stepwise management, and Rotterdam PCOS criteria.

Version 1.0 — Published April 2026
Quick Answer
The single costliest OBG mistake in NEET PG is confusing the three causes of antepartum hemorrhage (APH) — placenta previa, placental abruption, and vasa previa — because each has a distinct management pathway. To protect your 30-35 OBG marks:
- Build differentiation tables for clinical mimics — APH causes (previa vs abruption vs vasa previa), ovarian tumor families (epithelial, germ cell, sex cord), PPH etiologies (tone 70 percent, trauma 20 percent, tissue 10 percent, thrombin 1 percent)
- Memorize drug-trimester mapping — first-trimester teratogens (warfarin, valproate, isotretinoin, ACE inhibitors, methotrexate) vs 2nd-3rd trimester toxicities (ACE-induced renal dysgenesis, NSAID-induced ductus closure, tetracycline dental staining)
- Update to current guidelines — FIGO 2018 cervical cancer staging (new IB1/IB2/IB3 and IIIC with node status), WHO 2020 partograph (starts at 5 cm dilatation, no latent phase), Rotterdam 2003 PCOS criteria (2 of 3: oligo-anovulation, hyperandrogenism, polycystic ovaries on USG)
Why OBG mistakes are costly
Obstetrics and gynecology together contribute 30-35 questions to NEET PG, making OBG the second-highest-weighted clinical subject after medicine (2021-2024 pattern analysis). Unlike medicine, which tests disease mechanism and treatment, OBG tests decision-making under time pressure — recognizing the right antepartum hemorrhage etiology within minutes, choosing the right uterotonic sequence in PPH, picking the right contraception option by timing. A single conceptual error — for example, confusing placenta previa with abruption — can cost you 2-3 marks in the same paper because the wrong-answer logic cascades (previa mandates cesarean, abruption mandates urgent delivery based on maternal/fetal status, and the opposite choice leads to inappropriate downstream steps).
The ten mistakes below are the patterns that consistently appear in wrong-answer analyses from AIIMS, PGI, and private coaching institutes. Each mistake includes what students typically do, why it fails, the correct approach, and an example MCQ demonstrating the trap.
For comprehensive OBG strategy, pair this guide with the NEET PG OBG high-yield topics and the preeclampsia and eclampsia management guide.
Mistake 1: Confusing the stages of labor and their durations
What students do: Remember "3 stages" but forget the upper duration limits for each — leading to wrong answers about prolonged or precipitate labor.
Why it is wrong: Diagnosing prolonged labor (active phase arrest, second-stage arrest) requires knowing exact duration cut-offs. Missing the cut-off changes the answer from "normal progress — continue monitoring" to "diagnose prolonged labor — consider oxytocin or cesarean".
Correct approach: Memorize the 3-stage framework with updated WHO 2020 cut-offs.
| Stage | Definition | Primigravida max | Multigravida max |
|---|---|---|---|
| Stage 1 — latent phase | Onset of regular painful contractions to 5 cm dilatation | Up to 20 hours | Up to 14 hours |
| Stage 1 — active phase | 5 cm to full dilatation (10 cm) | >= 1 cm/hour (slow progress at 0.5 cm/hour acceptable) | >= 1.5 cm/hour expected |
| Stage 2 — expulsion | Full dilatation to delivery of baby | 2 hours (3 hours with epidural) | 1 hour (2 hours with epidural) |
| Stage 3 — placental | Delivery of baby to delivery of placenta | Up to 30 min (active management shortens to 5-15 min) | Up to 30 min |
| Stage 4 — recovery | First 1-2 hours postpartum (observation) | 1-2 hours | 1-2 hours |
Example MCQ: A primigravida at 40 weeks is in active labor. She reached 5 cm dilatation at 10 AM. Cervical examination at 2 PM shows 5 cm dilatation with adequate uterine contractions and intact membranes. The most appropriate next step is:
- (a) Continue observation for 2 more hours
- (b) Diagnose active phase arrest — consider amniotomy and oxytocin augmentation
- (c) Proceed to emergency cesarean section for failure to progress
- (d) Administer epidural analgesia for better pain relief
Answer: (b). No progress over 4 hours in active phase despite adequate contractions meets criteria for active phase arrest per WHO 2020 and ACOG (2014) — the first step is amniotomy (if intact) and oxytocin augmentation, NOT immediate cesarean. Cesarean is for failed augmentation or fetal distress.
Mistake 2: Mixing up APH causes (previa vs abruption vs vasa previa)
What students do: Attribute any antepartum bleeding to "placenta previa" without checking for tenderness, fetal status, or membrane timing.
Why it is wrong: Each cause has a distinct clinical signature, a different investigation, and a different immediate management. Getting this wrong cascades into wrong ABG/coagulation/delivery decisions.
Correct approach: Build a side-by-side APH comparison table and drill until automatic.
| Feature | Placenta previa | Placental abruption | Vasa previa |
|---|---|---|---|
| Timing | Usually after 28 weeks | Third trimester, can be earlier | Intrapartum, after membrane rupture |
| Bleeding | Painless, bright red | Painful, dark (sometimes concealed) | Painless, fresh bleeding with ROM |
| Uterus | Soft, non-tender | Tender, tense, woody | Soft, non-tender |
| Fetal status | Usually reassuring | Distress in 60 percent (IUFD in severe) | Acute fetal distress (sinusoidal FHR) |
| Maternal shock | Proportional to visible loss | Disproportionate to visible loss (concealed) | Proportional to minimal visible loss (fetal blood, not maternal) |
| USG | Low-lying placenta over os | Retroplacental clot (60 percent sensitive — clinical diagnosis) | Fetal vessels traversing os (color Doppler) |
| Apt test | Not diagnostic | Not diagnostic | POSITIVE for fetal Hb (alkali-resistant) |
| Coagulation | Usually normal | DIC in severe abruption (fibrinogen drop) | Usually normal maternal |
| Immediate management | Cesarean if bleeding; expectant if minor and stable | Urgent delivery if fetal distress or maternal instability; expectant if mild | Emergency cesarean |
Example MCQ: A G3P2 woman at 32 weeks presents with sudden painful vaginal bleeding and reduced fetal movements for 2 hours. Abdomen is tender with uterine tenderness and tonic contraction. FHR is 90 bpm with reduced variability. Maternal vitals: BP 100/60, HR 120, fibrinogen 1.2 g/L (low), platelets 90,000. The most likely diagnosis and next step are:
- (a) Placenta previa — urgent cesarean section
- (b) Placental abruption — urgent cesarean section and correct coagulopathy
- (c) Vasa previa — emergency cesarean section
- (d) Uterine rupture — laparotomy
Answer: (b). Painful bleeding + tender/woody uterus + fetal distress + DIC (fibrinogen 1.2, platelets 90,000) = placental abruption with DIC. Urgent cesarean plus correction of coagulopathy (FFP, cryoprecipitate, platelets) is the answer. Previa is painless; vasa previa requires prior membrane rupture.
Mistake 3: Wrong MgSO4 toxicity signs sequence
What students do: List MgSO4 toxicity signs randomly without knowing the dose-dependent sequence — respiratory depression and cardiac arrest feel "equal" rather than sequential.
Why it is wrong: Monitoring protocols depend on the sequence. You stop the infusion at loss of patellar reflex (first sign) — not at respiratory arrest. Missing the sequence means missing the window for safe discontinuation.
Correct approach: Memorize the dose-response cascade.
| Serum Mg (mEq/L) | Clinical effect | Action |
|---|---|---|
| 4-7 (therapeutic) | Seizure prophylaxis in eclampsia | Continue at 1 g/hour maintenance |
| 8-10 | Loss of deep tendon reflexes (patellar first) | Stop infusion immediately |
| 10-15 | Respiratory depression (RR < 12) | Stop infusion; give calcium gluconate 1 g IV slow; supportive ventilation |
| 15-25 | Muscle paralysis, cardiac conduction changes | Intubate if needed; calcium gluconate; dialysis if severe |
| > 25 | Cardiac arrest | CPR; calcium gluconate; urgent dialysis |
Pritchard regimen (still widely used in India): loading dose 4 g IV over 20 minutes PLUS 10 g IM (5 g in each buttock), followed by 5 g IM every 4 hours in alternate buttocks. Zuspan regimen: 4 g IV loading over 20 minutes followed by 1 g/hour IV infusion. Monitoring every 4 hours: patellar reflexes (present), respiratory rate (above 12), urine output (above 30 mL/hour). Antidote: calcium gluconate 1 g IV slowly over 3 minutes.
Example MCQ: A 28-year-old primigravida with preeclampsia is on IV MgSO4 infusion at 1 g/hour. After 6 hours, her patellar reflexes are absent but respiratory rate is 16/min and urine output 40 mL/hour. The most appropriate next step is:
- (a) Continue infusion — respiratory rate is normal
- (b) Stop the infusion immediately and monitor closely
- (c) Administer calcium gluconate 1 g IV slowly
- (d) Reduce the infusion rate to 0.5 g/hour
Answer: (b). Loss of patellar reflexes at serum Mg 8-10 mEq/L is the FIRST sign of toxicity. Stopping the infusion at this stage prevents progression to respiratory depression. Calcium gluconate is given only if respiratory depression occurs (step up from mere absent reflexes).
Mistake 4: Confusing teratogenic drugs by trimester
What students do: Label drugs as "teratogenic" without specifying which trimester and which malformation — leading to wrong answers about when to stop or switch.
Why it is wrong: First-trimester organogenesis (weeks 3-8) produces structural malformations; second and third trimester exposures produce functional defects or growth restriction. The same drug can be safe in one trimester and dangerous in another.
Correct approach: Memorize the trimester-specific teratogen table.
| Drug / class | First trimester (organogenesis) | 2nd-3rd trimester |
|---|---|---|
| Warfarin | Fetal warfarin syndrome (nasal hypoplasia, stippled epiphyses) at 6-12 weeks | CNS hemorrhage, microcephaly |
| Sodium valproate | Neural tube defects (1-2 percent), cleft palate, cardiac defects | Developmental delay |
| Carbamazepine | Neural tube defects, craniofacial defects | Vitamin K deficiency bleeding |
| Phenytoin | Fetal hydantoin syndrome (cleft lip/palate, hypoplastic distal phalanges) | Hemorrhagic disease of newborn |
| Isotretinoin | Severe CNS, cardiac, craniofacial defects | Contraindicated throughout |
| Methotrexate | Abortion, craniofacial defects | Contraindicated throughout |
| Lithium | Ebstein anomaly (1 percent) | Neonatal thyroid and renal dysfunction |
| ACE inhibitors / ARBs | Cardiovascular malformations | Fetal renal failure, oligohydramnios, skull ossification defects, death |
| Tetracyclines | Minimal risk | Dental staining, bone growth inhibition (after 15 weeks) |
| Aminoglycosides | Minimal risk | Ototoxicity (8th nerve damage) |
| NSAIDs | Minimal risk in early pregnancy | Premature ductus arteriosus closure, oligohydramnios after 30 weeks |
| Thalidomide | Phocomelia (limb shortening) at 4-8 weeks | Not used |
| Diethylstilbestrol (historical) | Clear cell adenocarcinoma of vagina in female offspring | Same |
Example MCQ: A 32-year-old woman at 30 weeks of pregnancy is hypertensive and started on enalapril. Three weeks later, ultrasound shows severe oligohydramnios and absent fetal renal function. The most likely mechanism is:
- (a) First-trimester teratogenic effect from the ACE inhibitor
- (b) Fetal renal dysgenesis from second-third trimester ACE inhibitor exposure
- (c) Placental insufficiency from maternal hypertension
- (d) Intrauterine infection
Answer: (b). ACE inhibitors in 2nd and 3rd trimester cause fetopathy — renal failure, oligohydramnios, skull ossification defects, pulmonary hypoplasia. ACE inhibitors and ARBs are contraindicated throughout pregnancy; switch to methyldopa or labetalol.
Mistake 5: Mixing up ovarian tumor types (epithelial vs germ cell vs sex cord)
What students do: Memorize individual tumor names (serous, dermoid, granulosa) without grouping them into the three developmental origins — leading to wrong marker and age-group answers.
Why it is wrong: Tumor group determines age profile, tumor markers, and commonly tested pathology features (Call-Exner bodies, Schiller-Duval bodies, psammoma bodies).
Correct approach: Classify every ovarian tumor into the correct origin group.
| Group | Frequency | Typical age | Representative tumors | Tumor markers | Pathology |
|---|---|---|---|---|---|
| Epithelial (65-70 percent) | 85-90 percent of malignant | Postmenopausal (50-70 y) | Serous (commonest, bilateral), mucinous, endometrioid, clear cell, Brenner | CA-125 (serous) | Psammoma bodies (serous), mucin-filled cells (mucinous) |
| Germ cell (15-20 percent) | 3-5 percent of malignant | Young (< 30 y) | Dysgerminoma, yolk sac (endodermal sinus), choriocarcinoma, teratoma (mature/immature) | LDH (dysgerminoma), AFP (yolk sac), hCG (choriocarcinoma) | Schiller-Duval bodies (yolk sac), sheets of germ cells (dysgerminoma), trophoblasts (choriocarcinoma) |
| Sex cord-stromal (5-10 percent) | 5 percent of malignant | Any age, hormonally active | Granulosa cell, Sertoli-Leydig, thecoma, fibroma | Inhibin, AMH (granulosa); testosterone (Sertoli-Leydig); none (fibroma) | Call-Exner bodies (granulosa), Reinke crystals (Leydig), Meigs triad (fibroma + ascites + hydrothorax) |
Example MCQ: An 18-year-old girl presents with abdominal pain and a large unilateral ovarian mass. Serum AFP is markedly elevated. Histology shows Schiller-Duval bodies (perivascular cells mimicking renal glomeruli). The most likely diagnosis is:
- (a) Serous cystadenocarcinoma
- (b) Yolk sac tumor (endodermal sinus tumor)
- (c) Dysgerminoma
- (d) Granulosa cell tumor
Answer: (b). Schiller-Duval bodies + elevated AFP + young patient = yolk sac tumor. Dysgerminoma has elevated LDH; granulosa cell has elevated inhibin and Call-Exner bodies; serous is postmenopausal with CA-125.
Mistake 6: Using outdated FIGO cervical cancer staging
What students do: Memorize FIGO 2009 staging where staging was purely clinical and stage IB cutoff was 4 cm — leading to wrong answers in questions that test FIGO 2018 updates.
Why it is wrong: FIGO 2018 is the current standard. It added imaging and pathology to upstage, created new IB1/IB2/IB3 subdivisions, and introduced stage IIIC for lymph node involvement.
Correct approach: Memorize FIGO 2018 cervical cancer staging.
| Stage | FIGO 2018 criteria |
|---|---|
| IA1 | Microinvasive, depth <= 3 mm |
| IA2 | Microinvasive, depth 3-5 mm |
| IB1 | Clinically visible or depth > 5 mm; tumor <= 2 cm |
| IB2 | Tumor 2-4 cm |
| IB3 | Tumor > 4 cm |
| IIA | Upper 2/3 vagina, no parametrium |
| IIB | Parametrial invasion, not reaching pelvic wall |
| IIIA | Lower 1/3 vagina |
| IIIB | Pelvic wall involvement OR hydronephrosis / non-functioning kidney |
| IIIC1 | Pelvic lymph node metastasis (regardless of tumor size) |
| IIIC2 | Para-aortic lymph node metastasis |
| IVA | Bladder or rectal mucosal invasion |
| IVB | Distant metastasis |
Treatment by stage (simplified): IA1 — extrafascial hysterectomy or cone biopsy if fertility desired. IA2-IB2 — radical hysterectomy with pelvic lymphadenectomy or chemoradiation. IB3-IVA — concurrent chemoradiation (cisplatin + external beam + brachytherapy). IVB — systemic chemotherapy, palliation.
Example MCQ: A 48-year-old woman has cervical cancer staged as tumor 3 cm confined to cervix on examination. PET-CT shows a single positive right pelvic lymph node with no para-aortic involvement. Per FIGO 2018, her stage is:
- (a) IB1
- (b) IB2
- (c) IIIC1
- (d) IIIB
Answer: (c). Per FIGO 2018, lymph node involvement (regardless of primary tumor size) upstages to IIIC — pelvic nodes = IIIC1, para-aortic nodes = IIIC2. Previously, the same patient under FIGO 2009 would have been staged IB2 purely by clinical assessment.
Mistake 7: Confusing emergency contraception options
What students do: Default to levonorgestrel regardless of time elapsed or BMI — missing cases where ulipristal or copper IUD is superior.
Why it is wrong: Time window and patient factors (BMI, ongoing contraception desire) determine optimal choice. Giving levonorgestrel at 96 hours wastes the opportunity for ulipristal or IUD.
Correct approach: Match option to time window and patient factors.
| Method | Time window | Efficacy | Mechanism | Best for |
|---|---|---|---|---|
| Copper IUD | Up to 120 hours (5 days) | > 99 percent | Inhibits fertilization + implantation | Patient wanting ongoing contraception; most effective option |
| Ulipristal acetate 30 mg | Up to 120 hours | 98 percent | Selective progesterone receptor modulator; delays/inhibits ovulation | 72-120 hour window; BMI > 26 |
| Levonorgestrel 1.5 mg | Up to 72 hours (best < 24 h) | 85-95 percent | Delays ovulation | < 72 hours, low BMI, available OTC |
| Yuzpe regimen (combined OCP) | Up to 72 hours | 75 percent | Ovulation inhibition + endometrial change | Last resort; high nausea/vomiting |
Example MCQ: A 30-year-old woman with BMI 30 presents 96 hours after unprotected intercourse seeking emergency contraception. She does NOT desire ongoing contraception. The most appropriate option is:
- (a) Levonorgestrel 1.5 mg single dose
- (b) Ulipristal acetate 30 mg single dose
- (c) Copper IUD insertion
- (d) Yuzpe regimen
Answer: (b). At 96 hours (beyond 72-hour levonorgestrel window) and with BMI 30 (reduced efficacy for levonorgestrel above BMI 26), ulipristal acetate is the most effective pill option within 120 hours. Copper IUD is most effective overall but is refused here. Yuzpe is outdated and less effective.
Mistake 8: Misreading the partograph (alert vs action line)
What students do: Treat the alert line as the cue for cesarean section, confusing it with the action line.
Why it is wrong: The alert line means "review and consider intervention" — it is a warning, not a mandate. The action line (4 hours right of alert) means "definitive intervention required". Mixing them up leads to premature cesarean or delayed augmentation.
Correct approach: Learn the updated WHO 2020 partograph structure.
| Feature | Alert line | Action line |
|---|---|---|
| Position | Diagonal line from 5 cm to 10 cm at 1 cm/hour | 4 hours to the right of alert line |
| Interpretation | Expected rate of progress in active labor | Intervention threshold |
| Action on crossing | Review hydration, analgesia, fetal position, contraction pattern; consider amniotomy if intact | Definitive intervention: oxytocin augmentation if no contraindication; cesarean if oxytocin contraindicated or fetal distress |
| Plotted parameters | Cervical dilatation (active phase from 5 cm) | Same |
| Other plots | Fetal heart rate, contractions (frequency and duration), descent (fifths palpable), maternal vitals (BP, pulse, temperature), urine, drugs given | Same |
The WHO 2020 simplified partograph removed the latent phase plotting and starts at 5 cm dilatation. The older Friedman curve (used the 4 cm cutoff with 1 cm/hour expected) is outdated — current NEET PG questions follow WHO 2020.
Example MCQ: A G2P1 woman in active labor has her cervical dilatation plotted on a WHO partograph. Her plot has just crossed the alert line but not yet the action line. Membranes are intact, FHR is reassuring, and contractions are 2 in 10 minutes lasting 30 seconds. The most appropriate next step is:
- (a) Immediate emergency cesarean section
- (b) Amniotomy and reassessment; consider oxytocin if no improvement by action line
- (c) Administer tocolytics to halt labor
- (d) Observe for 4 more hours without intervention
Answer: (b). Alert line crossing is the review stage — optimize contractions first by amniotomy (if intact) and prepare for oxytocin augmentation if progress remains slow by the action line. Immediate cesarean at alert line is premature. Tocolytics are contraindicated in established labor.
Mistake 9: Wrong stepwise PPH management (skipping bimanual compression)
What students do: Jump from drug therapy (oxytocin, methylergometrine, carboprost) directly to surgical intervention, skipping the low-cost, high-impact step of bimanual uterine compression.
Why it is wrong: Bimanual compression is the immediate bedside step that provides mechanical tamponade while drugs take effect. Skipping it delays hemostasis and often features as the expected answer in sequence MCQs.
Correct approach: Memorize the PPH stepwise algorithm (4 T's etiology — Tone 70 percent, Trauma 20 percent, Tissue 10 percent, Thrombin 1 percent).
Step-by-step for atonic PPH (commonest, 70 percent):
- Call for help — two IV lines, crossmatch, bloods (CBC, coagulation, fibrinogen).
- Bimanual uterine compression (one hand in vagina, other on abdomen compressing uterus) — immediate bedside tamponade while preparing uterotonics.
- First-line uterotonic: IV oxytocin 10 U slow bolus + 40 U in 500 mL crystalloid at 125 mL/hour.
- Second-line uterotonics if atony persists:
- Methylergometrine 0.2 mg IM (contraindicated in hypertension, preeclampsia)
- Carboprost (15-methyl PGF2-alpha) 250 mcg IM every 15 minutes, max 8 doses (contraindicated in asthma)
- Misoprostol 800-1000 mcg rectal or sublingual (good in hypertension and asthma)
- Tranexamic acid 1 g IV over 10 minutes — within 3 hours of onset (WOMAN trial, Lancet 2017, showed 31 percent reduction in death from bleeding).
- Intrauterine balloon tamponade (Bakri balloon or condom catheter) — if drugs fail.
- Surgical procedures:
- B-Lynch compression suture (brace suture) — compresses uterus
- Uterine artery ligation (O'Leary)
- Internal iliac artery ligation (bilateral)
- Uterine artery embolization (if interventional radiology available)
- Peripartum hysterectomy — last resort when all conservative measures fail.
Example MCQ: A G3P3 woman delivers vaginally and 10 minutes later develops heavy vaginal bleeding with a soft, flabby uterus. BP is 100/60. Per stepwise PPH management, after calling for help and establishing IV access, the IMMEDIATE next step is:
- (a) Administer methylergometrine 0.2 mg IM
- (b) Bimanual uterine compression while starting IV oxytocin
- (c) Proceed to Bakri balloon insertion
- (d) Urgent hysterectomy
Answer: (b). Bimanual uterine compression is the immediate mechanical maneuver during resuscitation — it provides tamponade while IV oxytocin takes effect. Methylergometrine is second-line (and contraindicated if BP is not verified). Balloon tamponade is after uterotonics fail. Hysterectomy is last resort.
Mistake 10: Confusing PCOS Rotterdam criteria
What students do: Remember "PCOS needs all 3 criteria" — missing that Rotterdam 2003 requires only 2 of 3.
Why it is wrong: The Rotterdam criteria are 2-of-3 (NOT all 3), which is why PCOS can be diagnosed even without visible cysts on ultrasound. Misapplying as all-3 leads to under-diagnosis.
Correct approach: Memorize the 2003 Rotterdam criteria — need any 2 of 3.
| Criterion | Definition |
|---|---|
| 1. Oligo-ovulation or anovulation | Cycles > 35 days OR < 8 cycles/year OR absence of menses |
| 2. Clinical or biochemical hyperandrogenism | Hirsutism (modified Ferriman-Gallwey >= 8), acne, male-pattern alopecia, OR elevated testosterone / DHEA-S / androstenedione |
| 3. Polycystic ovaries on USG | >= 12 follicles (2-9 mm) in one ovary OR ovarian volume > 10 mL |
Exclusion criteria (must rule out): thyroid dysfunction (TSH), hyperprolactinemia (PRL), non-classical CAH (17-OH progesterone), Cushing syndrome, androgen-secreting tumors (DHEA-S, total testosterone), acromegaly.
AE-PCOS Society 2006 criteria (stricter, emphasized in some textbooks): REQUIRES hyperandrogenism + (oligo-ovulation OR polycystic ovaries).
Management pillars:
- Lifestyle (first-line) — weight loss of 5-10 percent restores ovulation in 60 percent of overweight PCOS patients
- Metformin — for insulin resistance, cycle regulation (not first-line for fertility)
- Combined OCPs — cycle regulation, hyperandrogenism; contains ethinylestradiol + anti-androgenic progestin (cyproterone acetate, drospirenone)
- Letrozole (first-line for ovulation induction) — superior to clomiphene in live birth rates (NEJM 2014, PPCOS II trial)
- Clomiphene citrate — traditional first-line, now second-line to letrozole
- Gonadotrophins / IVF — if above fail
Example MCQ: A 24-year-old woman with irregular periods (4 per year) and mild acne has normal ultrasound with no polycystic appearance. Her free testosterone is 3 times the upper limit. TSH, prolactin, and 17-OH progesterone are normal. Per Rotterdam 2003 criteria, she:
- (a) Does NOT meet criteria for PCOS (needs polycystic ovaries)
- (b) Meets criteria for PCOS (oligo-ovulation + hyperandrogenism)
- (c) Requires a trial of OCPs before diagnosis
- (d) Has non-classical CAH
Answer: (b). Rotterdam 2003 requires ANY 2 of 3. She has oligo-ovulation (4 cycles/year) and hyperandrogenism (elevated free testosterone) — 2 criteria met, other causes excluded. Polycystic ovaries on USG are NOT mandatory.
Comparison table: mistake vs correct approach
| Mistake | What students do | Correct approach |
|---|---|---|
| Stages of labor confusion | Skip duration cut-offs | Memorize stage 1 (latent, active), 2 (2 h primi / 1 h multi), 3 (up to 30 min), 4 (1-2 h) |
| APH etiology mix-up | Call every APH "previa" | Distinguish previa (painless, soft), abruption (painful, tender, DIC), vasa previa (fetal bleeding, Apt test +) |
| Wrong MgSO4 toxicity order | List random signs | Memorize sequence: absent reflexes (8-10 mEq/L) → respiratory depression (10-15) → paralysis (15-25) → arrest (> 25) |
| Teratogen-trimester confusion | Label drug as "teratogenic" without trimester | Classify by trimester: 1st = structural (warfarin, valproate, isotretinoin); 2nd-3rd = functional (ACE, NSAIDs, aminoglycosides, tetracyclines) |
| Ovarian tumor confusion | Memorize tumors individually | Group into epithelial (CA-125, postmenopausal), germ cell (LDH/AFP/hCG, young), sex cord (inhibin, hormonally active) |
| Outdated FIGO staging | Use FIGO 2009 | Use FIGO 2018: new IB1/IB2/IB3 and IIIC (node status) |
| Emergency contraception | Default to levonorgestrel | Match window and BMI: copper IUD best, ulipristal for 72-120 h and BMI > 26, LNG < 72 h |
| Partograph misreading | Treat alert as action line | Alert = warning (review, optimize); action (4 h right of alert) = intervention (oxytocin or cesarean) |
| PPH skipping bimanual compression | Jump to drugs or surgery | Call help → bimanual compression → oxytocin → second-line uterotonics → TXA → balloon → surgical |
| PCOS diagnostic error | Require all 3 criteria | Rotterdam 2003 needs ANY 2 of 3 after excluding thyroid, prolactin, CAH, Cushing |
Self-check checklist
Before your next OBG revision session, verify you can answer each of these without looking:
- Name the 3 stages of labor with upper duration limits for primigravida and multigravida
- Distinguish placenta previa, placental abruption, and vasa previa on 4 clinical features
- Recite MgSO4 toxicity signs in order of serum level (4 stages)
- Name 3 first-trimester teratogens and 3 2nd-3rd trimester toxicities
- Match 3 ovarian tumor groups (epithelial, germ cell, sex cord) to age, markers, and pathology features
- Stage a cervical cancer case using FIGO 2018 (include IIIC node criteria)
- Choose the correct emergency contraception for a 96-hour post-unprotected-intercourse case with BMI 30
- Define alert line vs action line on WHO 2020 partograph
- Order the 8-step PPH management sequence (bimanual compression to hysterectomy)
- State the Rotterdam 2003 PCOS criteria (2 of 3) with exclusions
If you hesitate on more than 2 items, revisit the corresponding mistake section above.
Frequently asked questions
How many OBG questions appear in NEET PG?
Obstetrics and gynecology together contribute 30-35 questions in NEET PG (2021-2024 pattern analysis) — roughly 15-18 obstetrics (labor, APH, PPH, preeclampsia, teratology) and 15-17 gynecology (ovarian tumors, cervical cancer staging, PCOS, contraception, menopause). OBG is the second-highest-weighted clinical subject after medicine. The NBE tests patterns that combine obstetric physiology with pharmacology (MgSO4, uterotonics) and surgical decision-making (cesarean indication, hysterectomy). A single conceptual error — for example, confusing placenta previa with placental abruption — can cost 2-3 marks across the same paper.
What is the commonest OBG mistake in NEET PG?
Confusing the three causes of antepartum hemorrhage (APH) is the costliest OBG mistake. Placenta previa is painless bright-red bleeding with a soft, non-tender uterus and no fetal distress. Placental abruption is painful dark bleeding (sometimes concealed) with a tender, tense, woody uterus and fetal distress in 60 percent. Vasa previa is painless bleeding with acute fetal distress after membrane rupture (fetal blood loss — Apt test positive for fetal hemoglobin). Each has a distinct management pathway — previa mandates cesarean if bleeding, abruption mandates urgent delivery if fetal distress or maternal instability, vasa previa mandates immediate cesarean. Build a three-column comparison table and drill it until automatic.
How do I remember MgSO4 toxicity signs in the correct order?
Magnesium sulfate toxicity follows a predictable dose-dependent sequence by serum level. Therapeutic range for eclampsia prophylaxis is 4-7 mEq/L. Loss of deep tendon reflexes (patellar) appears first at 8-10 mEq/L — this is why reflex monitoring is the single most important bedside assessment. Respiratory depression appears at 10-15 mEq/L (respiratory rate below 12/min). Cardiac arrest occurs at above 25 mEq/L. Monitoring protocol before each dose: patellar reflexes present, respiratory rate above 12/min, urine output above 30 mL/hour over 4 hours, serum magnesium if level of consciousness altered. Antidote is calcium gluconate 1 g IV slowly over 3 minutes.
Which drugs are teratogenic in which trimester?
First trimester (organogenesis, weeks 3-8) is the highest-risk period for structural malformations. Classic first-trimester teratogens: warfarin (nasal hypoplasia, stippled epiphyses — fetal warfarin syndrome), sodium valproate (neural tube defects, cleft lip/palate), carbamazepine (neural tube defects), phenytoin (fetal hydantoin syndrome — cleft lip/palate, hypoplastic distal phalanges), isotretinoin (CNS, cardiac, craniofacial malformations), thalidomide (phocomelia), methotrexate, ACE inhibitors and ARBs (renal dysgenesis — contraindicated throughout pregnancy but especially 2nd-3rd trimester). Second-third trimester toxicities: ACE inhibitors (fetal renal failure, oligohydramnios, skull defects), tetracyclines (dental discoloration, bone growth), aminoglycosides (ototoxicity), NSAIDs (premature ductus closure, oligohydramnios after 30 weeks).
How do I distinguish epithelial, germ cell, and sex cord ovarian tumors?
Epithelial tumors (65-70 percent of ovarian neoplasms, most malignant, postmenopausal women) — serous (commonest, often bilateral, psammoma bodies), mucinous (pseudomyxoma peritonei), endometrioid, clear cell, Brenner; CA-125 elevated. Germ cell tumors (15-20 percent, young women under 30) — dysgerminoma (ovarian counterpart of seminoma, LDH elevated, radiosensitive), yolk sac tumor (AFP elevated, Schiller-Duval bodies), choriocarcinoma (hCG elevated), mature cystic teratoma (dermoid — commonest benign, contains hair/teeth/sebaceous). Sex cord-stromal tumors (5-10 percent, hormonally active) — granulosa cell (estrogen-secreting, Call-Exner bodies, postmenopausal bleeding), Sertoli-Leydig (androgen-secreting, virilization), thecoma (estrogen), fibroma (Meigs syndrome — ascites, hydrothorax, ovarian fibroma).
What changed in FIGO 2018 cervical cancer staging?
FIGO 2018 cervical cancer staging incorporated imaging and pathology, changing several critical substages. Stage IB was subdivided: IB1 (tumor 2 cm or less), IB2 (2-4 cm), IB3 (above 4 cm) — previously only IB1 (4 cm or less) and IB2 (above 4 cm). Stage IIIC was newly added based on lymph node involvement regardless of tumor size: IIIC1 (pelvic nodes), IIIC2 (para-aortic nodes) — this means a small primary tumor with positive nodes jumps from IB to IIIC. Stage IVA (bladder/rectum invasion) and IVB (distant metastasis) are unchanged. Imaging (CT, MRI, PET-CT) and pathology can now upstage, whereas FIGO 2009 was strictly clinical. For NEET PG, memorize the new 2018 cutoffs — questions referencing 'FIGO 2009 staging' are outdated.
Which emergency contraception option should I choose for a given case?
Four options with different time windows and efficacy. Copper IUD (most effective) — within 120 hours (5 days) of unprotected intercourse, above 99 percent effective, provides ongoing contraception, preferred if the patient desires long-term contraception. Ulipristal acetate 30 mg single dose — within 120 hours, effective even in the 72-120 hour window (second most effective pill). Levonorgestrel 1.5 mg single dose — within 72 hours, efficacy drops rapidly after 72 hours, widely available over-the-counter in India. Yuzpe regimen (combined OCPs) — within 72 hours, higher nausea/vomiting, largely replaced by dedicated products. Ulipristal is superior to levonorgestrel in the 72-120 hour window and in overweight women (BMI above 26). For NEET PG, match the time window to the correct choice.
How do I read a partograph without missing alert or action line crossings?
Modern WHO simplified partograph (2020) removed the latent phase and starts plotting at active labor (cervical dilatation 5 cm). The alert line moves diagonally at 1 cm/hour from 5-10 cm dilatation. Crossing the alert line means labor is abnormally slow — review maternal hydration, analgesia, and fetal position, consider amniotomy. The action line is 4 hours to the right of the alert line — crossing the action line mandates definitive intervention (oxytocin augmentation if no contraindication, OR cesarean if contraindication or fetal distress). Plot descent (station, fifths palpable per abdomen), cervical dilatation, fetal heart rate, contractions, and maternal vitals at defined intervals. Common trap: candidates confuse the old Friedman curve (which included latent phase and used 1 cm/hour from 4 cm) — use the updated WHO partograph for current NEET PG patterns.
This content is for educational purposes for NEET PG exam preparation. It is not a substitute for professional medical advice, diagnosis, or treatment. Clinical information has been reviewed by qualified medical professionals.
Sources and references
- DC Dutta's Textbook of Obstetrics, 9th Edition (Konar, 2018) — the standard Indian OBG textbook for NEET PG with current labor, PPH, and APH protocols.
- Berek and Novak's Gynecology, 16th Edition (Wolters Kluwer, 2019) — comprehensive gynecology reference for ovarian tumors, cervical cancer staging, and PCOS.
- WHO, "Recommendations on Labour and Intrapartum Care for a Positive Childbirth Experience," World Health Organization, 2018 (updated 2020) — updated partograph framework (starts at 5 cm, no latent phase plotting).
Master OBG patterns by practicing MCQs that test these exact trap points. Start with the obstetrics-gynecology subject page, review the NEET PG OBG high-yield topics, and deepen your hypertensive-disorders reasoning with the preeclampsia and eclampsia management guide. Ready for unlimited AI-powered MCQs? Explore NEETPGAI Pro.
Build your personalized OBG study plan with the AI planner — it identifies your weak topics and schedules targeted revision.
Written by: NEETPGAI Editorial Team Reviewed by: Pending SME Review Last reviewed: April 2026
This article is reviewed by qualified medical professionals for clinical accuracy and exam relevance. For corrections or updates, contact the editorial team.
This content is for educational purposes for NEET PG exam preparation. It is not a substitute for professional medical advice, diagnosis, or treatment. Clinical information has been reviewed by qualified medical professionals.
Ready to put this into practice?
Start practicing NEET PG MCQs with AI-powered explanations.
Start Free PracticeYour Next Step
Related Study Guides
How to Revise Mistakes With AI Flashcards for NEET PG — A 10-Step Personal Mistake-Bank Protocol
Build a personal NEET PG mistake-bank with AI flashcards: error taxonomy, mock-test extraction, Anki vs RemNote vs NEETPGAI, spaced repetition cadence, leech card management, last-week protocol.
15 Common Mistakes in Psychiatry for NEET PG — And How to Avoid Them
Avoid the costliest psychiatry mistakes in NEET PG 2026: schizophrenia subtypes, mood disorder duration, suicide risk, antipsychotic side effects, ECT, dementia vs delirium, MHCA 2017.
How to Build a Personalized NEET PG 2026 Study Plan With AI — A Practical 9-Step Guide
Build a personalised AI-powered NEET PG study plan: diagnostic baseline, subject prioritisation by weightage, spaced repetition, AI tutor, mock analysis, 12/6/3/1-month templates.
Join our NEET PG community
Daily MCQs, study tips, and topper strategies on Telegram.
Join on Telegram →